Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Parshottam Koradia"'
Autor:
Shashi Bhushan B L, Sunil Wanve, Parshottam Koradia, Vinay Bhomia, Pravin Soni, Sisir Chakraborty, Akash Khobragade, Shashank Joshi, Sanjeev Kumar Mendiratta, Kevin Kumar Kansagra, Anurag Parihar, Sunil Sharma, Jatin Patel
Publikováno v:
International Journal of Infectious Diseases, Vol 111, Iss , Pp 281-287 (2021)
Objective: To evaluate the efficacy and safety of pegylated interferon alpha-2b (PEG IFN-α2b) administered in conjunction with the standard of care (SOC) in subjects with moderate coronavirus disease-19 (COVID-19). Methods: In this study, adult subj
Externí odkaz:
https://doaj.org/article/4224fcf9b36b4c10afc34d1cc3b29bf7
Autor:
Anuja Pandit, Nirav Bhalani, B.L. Shashi Bhushan, Parshottam Koradia, Shweta Gargiya, Vinay Bhomia, Kevinkumar Kansagra
Publikováno v:
International Journal of Infectious Diseases, Vol 105, Iss , Pp 516-521 (2021)
Objective: To evaluate the efficacy and safety of pegylated interferon alfa-2b (PEG IFN-α2b) along with the standard of care (SOC) in subjects with moderate COVID-19. Methods: In this phase 2, randomized, open-label study, adult subjects aged ≥18
Externí odkaz:
https://doaj.org/article/db1045fd9fbc4939a9d4129a5d9bf40c
Autor:
Anuja Pandit, Nirav Bhalani, B.L. Shashi Bhushan, Parshottam Koradia, Shweta Gargiya, Vinay Bhomia, Kevinkumar Kansagra
Publikováno v:
International Journal of Infectious Diseases, Vol 109, Iss , Pp 322- (2021)
Externí odkaz:
https://doaj.org/article/a241828a658d44b9a2af2cd2625831a8
Autor:
Akash, Khobragade, Suresh, Bhate, Vijendra, Ramaiah, Shrikant, Deshpande, Krishna, Giri, Himanshu, Phophle, Pravin, Supe, Inderjeet, Godara, Ramesh, Revanna, Rajnish, Nagarkar, Jayesh, Sanmukhani, Ayan, Dey, T M Chozhavel, Rajanathan, Kevinkumar, Kansagra, Parshottam, Koradia
Publikováno v:
The Lancet. 399:1313-1321
ZyCoV-D, a DNA-based vaccine, showed promising safety and immunogenicity in a phase 1/2 trial. We now report the interim efficacy results of phase 3 clinical trial with ZyCoV-D vaccine in India.We conducted an interim analysis of a multicentre, doubl
Autor:
Dhananjai, Agrawal, Deepak, Varade, Hardik, Shah, Alm, Nazar, Jayakumar, Krishnan, Vineet, Shukla, Chinta, Ramakrishna, Mahel Chinthana, Bandara Galahitiyawa, Sidhharth B, Mavani, Sunil, Rajanna, Petkar, Jikki, Shamila, De Silva, Vivek, Ruhela, Parshottam, Koradia, Kevinkumar, Kansagra, Pooja, Kanani, Nitin, Sharma, Kuldipsinh, Zala, Deven, Parmar
Publikováno v:
American journal of nephrology. 53(5)
Desidustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, is being developed to treat anemia in patients with chronic kidney disease (CKD) without dialysis dependency.In total, 588 patients with a clinical diagnosis of anemia due to
Autor:
Anurag Parihar, Shashi Bhushan B L, Jatin Patel, Pravin Soni, Vinay Bhomia, Parshottam Koradia, Sunil Sharma, Sanjeev Kumar Mendiratta, Akash Khobragade, Sunil Wanve, Sisir Chakraborty, Shashank R Joshi, Kevin Kumar Kansagra
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 111, Iss, Pp 281-287 (2021)
International Journal of Infectious Diseases, Vol 111, Iss, Pp 281-287 (2021)
Objective To evaluate the efficacy and safety of pegylated interferon alpha-2b (PEG IFN-α2b) administered in conjunction with the standard of care (SOC) in subjects with moderate coronavirus disease-19 (COVID-19). Methods In this study, adult subjec
Autor:
Nirav Bhalani, Anuja Pandit, Parshottam Koradia, Vinay Bhomia, Kevinkumar Kansagra, B.L. Shashi Bhushan, Shweta Gargiya
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 105, Iss, Pp 516-521 (2021)
International Journal of Infectious Diseases, Vol 105, Iss, Pp 516-521 (2021)
Objective: To evaluate the efficacy and safety of pegylated interferon alfa-2b (PEG IFN-α2b) along with the standard of care (SOC) in subjects with moderate COVID-19. Methods: In this phase 2, randomized, open-label study, adult subjects aged ≥18
Autor:
Nirav Bhalani, Kevinkumar Kansagra, Anuja Pandit, Parshottam Koradia, Vinay Bhomia, Shweta Gargiya, B.L. Shashi Bhushan
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 109, Iss, Pp 322-(2021)
International Journal of Infectious Diseases, Vol 109, Iss, Pp 322-(2021)
To evaluate the efficacy and safety of pegylated interferon alfa-2b (PEG IFN-α2b) along with the standard of care (SOC) in subjects with moderate COVID-19.In this phase 2, randomized, open-label study, adult subjects aged ≥18 years with RT-PCR con
Publikováno v:
Expert review of anti-infective therapy. 17(9)
Objectives: To assess efficacy and safety of Bio-Kult Pro-Cyan (BKPro-Cyan), a product containing two strains of Lactobacilli plus cranberry extract, for preventing recurrent UTIs in pre-menopausal adult women.Methods: This was a randomized, double-b